Comparative Effectiveness of a Breath-Operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

This study has been completed.

First Received: February 14, 2003 Last Updated: May 6, 2008 History of Changes

Sponsor:	Teva Global Respiratory Research LLC
Information provided by:	Teva Global Respiratory Research LLC
ClinicalTrials.gov Identifier:	NCT00054964

Purpose

This study is designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.

Condition	Intervention	Phase
Asthma	Drug: Albuterol	Phase II

Study Type:	Interventional
Study Design:	Treatment

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Drug Information available for: Albuterol Levalbuterol hydrochloride Albuterol sulfate Levalbuterol tartrate

U.S. FDA Resources

Further study details as provided by Teva Global Respiratory Research LLC:

Study Start Date:

March 2003

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Stable asthma
Poor inhaler coordination technique.

Exclusion Criteria:

Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting beta-blockers, steroids other than those inhaled

Contacts and Locations

No Contacts or Locations Provided

More Information

No publications provided

Study ID Numbers:	IXR-202-4-167
Study First Received:	February 14, 2003
Last Updated:	May 6, 2008
ClinicalTrials.gov Identifier:	NCT00054964 History of Changes
Health Authority:	United States: Food and Drug Administration

Additional relevant MeSH terms:

Respiratory System Agents
Neurotransmitter Agents
Bronchial Diseases
Adrenergic Agents
Molecular Mechanisms of Pharmacological Action
Albuterol
Physiological Effects of Drugs
Reproductive Control Agents
Adrenergic Agonists
Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Tocolytic Agents

Therapeutic Uses
Immune System Diseases
Adrenergic beta-Agonists
Asthma
Anti-Asthmatic Agents
Pharmacologic Actions
Autonomic Agents
Lung Diseases
Hypersensitivity, Immediate
Peripheral Nervous System Agents
Bronchodilator Agents
Respiratory Hypersensitivity

ClinicalTrials.gov processed this record on November 27, 2009